Crypto Briefing

Zoomex strengthens liquidity infrastructure to meet growing demand from AI trading systems

Fast rising crypto exchange, Zoomex has outlined its approach to liquidity and execution quality as artificial intelligence ...

Celebrating Women's History Month: Women who transformed manufacturing over the last 125 years

TeamSense reports on the vital contributions of women in manufacturing over 125 years, highlighting their roles in labor ...

Want To Handle Stress Better? Science Recommends These Surprising Daily Habits

Healthy daily habits may do more than support physical health, they may also help the mind stay adaptable when stress strikes ...
Morning Overview on MSN

Researchers use vibrating molecules to catapult electrons in solar films

Scientists at the University of Cambridge have found that vibrating molecules can launch electrons across solar cell ...

The curious case of low-protein diets

Knowable Magazine reports on low-protein diets, suggesting they may extend lifespan in mice by lowering growth signals and improving metabolic health.
The Manila Times

Polaryx Therapeutics Receives FDA Fast Track Designation for PLX‑200 for Late‑Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)

Regulatory milestone supports advancement of the SOTERIA Phase 2 basket trial evaluating PLX‑200 across multiple lysosomal storage disorders PARAMUS, NJ, March 17, 2026 (GLOBE NEWSWIRE) -- Polaryx ...

The ‘quiet workhorse’ of the renewable energy transition

And when the thermometers tick up, so does energy demand due to electricity-hungry air conditioners. The state’s grid ...
Edutopia

Research-Backed Strategies to Keep Students on Task

Teachers can help students build their capacity to stay on task by ensuring that they have a clear path to start working, ...
Campaign Brief Asia

Vantage Picture’s James Duong on bringing Chinese productions to Vietnam

For James Duong, Executive Producer at Vantage Pictures, producing isn’t just about getting a shoot done - it’s about building a bridge.

Polaryx Therapeutics, Inc.: Polaryx Therapeutics Receives FDA Fast Track Designation for PLX-200 for Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)

Regulatory milestone supports advancement of the SOTERIA Phase 2 basket trial evaluating PLX-200 across multiple lysosomal storage disorders PARAMUS, NJ, March 17, 2026 (GLOBE NEWSWIRE) -- Polaryx The ...
Studywithemmane on MSN

Study with me how to build focus and stay productive

Study effectively with me and discover simple techniques to unlock deep focus and improve productivity. Learn practical study ...